![R. Douglas Shytle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
R. Douglas Shytle
Plus aucun poste en cours
Profil
Dr. R.
D.
Shytle is an Advisor at Select BioVentures LLC.
Dr. Shytle was previously employed as an Associate Professor by University of South Florida, a Consultant by AstraZeneca LP, a Consultant by Ceptaris Therapeutics, Inc., a Consultant by Pfizer Inc., and a Consultant by Targacept, Inc.
Dr. Shytle received his PhD in Neuroscience from the University of Wyoming in 1994.
Anciens postes connus de R. Douglas Shytle
Sociétés | Poste | Fin |
---|---|---|
Targacept, Inc.
![]() Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | Consultant / Advisor | - |
Ceptaris Therapeutics, Inc.
![]() Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Consultant / Advisor | - |
AstraZeneca LP
![]() AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Consultant / Advisor | - |
PFIZER, INC. | Consultant / Advisor | - |
University of South Florida | Corporate Officer/Principal | - |
Formation de R. Douglas Shytle
University of Wyoming | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PFIZER, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Select BioVentures LLC
![]() Select BioVentures LLC Investment ManagersFinance Founded in 2012, Select BioVentures LLC is a venture capital firm located in Palm Beach, Florida. | Finance |
AstraZeneca LP
![]() AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Ceptaris Therapeutics, Inc.
![]() Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |
Targacept, Inc.
![]() Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | Health Technology |